Your SlideShare is downloading. ×
Pharmaceutical industry
Pharmaceutical industry
Pharmaceutical industry
Pharmaceutical industry
Pharmaceutical industry
Pharmaceutical industry
Pharmaceutical industry
Pharmaceutical industry
Pharmaceutical industry
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Pharmaceutical industry


Published on

  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Pharmaceutical industry
  • 2. Introduction
    • Pharmaceutical industry develops , produces ,markets drugs licensed for medications.
    • They deal in generic/brand medications.
    • They are subject to variety of laws and regulations regarding the patenting , testing and marketing of drugs.
  • 3. history
    • First known drug store was opened by the Arabian pharmacist in Baghdad in 754
    • By 19 th century drug stores in Europe and America converted into pharmaceutical companies.
    • Key discoveries of 1920s-1930s were insulin and penicillin.
    • Legislation was enacted to test and approve drugs and to require appropriate labeling of prescription and non-prescription drugs became legally distinguish from one another as the pharmaceutical industry matured.
  • 4. Research and development
    • Drug discovery is the process by which drugs are discovered and designed.
    • In the past drugs were discovered by isolating the active ingredient from traditional remedies.
    • Modern biotechnology focuses on the metabolic pathways related to a disease state or a pathogen.
    • Drug development refers to the activities undertaken after a compound is identified as a potential drug in order to establish its suitability as a medication.
    • Objective is to provide adequate formulation and dosing for safety.
  • 5. Pharmaceutical company in india
    • In India it is an emerging sector as by providing a standard generic drugs according to the act 1970.
    • This sector is predicted to value about $3.1billion.
  • 6. Growth in India
    • It has witnessed about 4.0% (CAGR) over 2007.
    • India has also appeared as a preferred location for the pharmaceutical industry because of its towering growth scenario furnished by elderly population ,alteration in disease profile developing patent system and socio-economic circumstances.
    • The competition in the Indian market is cutthroat among the top 10 Pharma companies.
    • India began to abide by the world trade organization's trade related aspects of intellectual property rights after the revision of the Indian patent act in January 2005.
  • 7. Major issues
    • Severe competition: low margins and restricted capital to assist R&D is the result of intense pricing competition among the local producers.
    • Failure of new patient system : if any composition already exists in the market one can not bring that in market again.
    • Lack of proper infrastructure: issues associated with regular power cuts and lack of transportation facilities decrease the expansion of this sector.
  • 8. Top 10 pharmaceutical companies
    • Ranbaxy Laboratories
    • Dr. Reddy's Laboratories
    • Cipla
    • Sun Pharmaceuticals
    • Lupin Labs
    • Aurobindo Pharma
    • GlaxoSmithKlineg
    • Cadila Healthcare
    • Aventis Pharma
    • Ipca Laboratories
  • 9. Thank you